Chromothripsis in Treatment Resistance in Multiple Myeloma
Kyoung Joo Lee, Ki Hong Lee, Kyong-Ah Yoon, Ji Yeon Sohn, Eunyoung Lee, Hyewon Lee, Hyeon-Seok Eom, Sun-Young Kong
Genomics Inform. 2017;15(3):87-97.   Published online 2017 Sep 28     DOI: https://doi.org/10.5808/GI.2017.15.3.87
Citations to this article as recorded by Crossref logo
Chromothripsis in hematologic malignancies
Francisco Alejandro Lagunas-Rangel
Experimental Hematology.2024; 132: 104172.     CrossRef
Chromothripsis: an emerging crossroad from aberrant mitosis to therapeutic opportunities
Umer Ejaz, Zhen Dou, Phil Y Yao, Zhikai Wang, Xing Liu, Xuebiao Yao, Zhiyuan Shen
Journal of Molecular Cell Biology.2024;[Epub]     CrossRef
Pan-cancer analysis of chromothripsis-related gene expression patterns indicates an association with tumor immune and therapeutic agent responses
Qin Zhang, Lujie Yang, He Xiao, Zhaoqian Dang, Xunjie Kuang, Yanli Xiong, Jianwu Zhu, Zhou Huang, Mengxia Li
Frontiers in Oncology.2023;[Epub]     CrossRef
Disentangling the roles of aneuploidy, chromosomal instability and tumour heterogeneity in developing resistance to cancer therapies
Joana Reis Andrade, Annie Dinky Gallagher, Jovanna Maharaj, Sarah Elizabeth McClelland
Chromosome Research.2023;[Epub]     CrossRef
Chromoanagenesis, the mechanisms of a genomic chaos
F. Pellestor, JB Gaillard, A. Schneider, J. Puechberty, V. Gatinois
Seminars in Cell & Developmental Biology.2022; 123: 90.     CrossRef
Ultra-low coverage whole genome sequencing of ccfDNA in multiple myeloma: A tool for laboratory routine?
Laura Yissel Rengifo, Sanne Smits, Lieselot Buedts, Michel Delforge, Luc Dehaspe, Thomas Tousseyn, Nancy Boeckx, Stefan Lehnert, Lucienne Michaux, Joris Robert Vermeesch, Peter Vandenberghe, Barbara Dewaele
Cancer Treatment and Research Communications.2021; 28: 100380.     CrossRef
Genome Instability in Multiple Myeloma: Facts and Factors
Anna Y. Aksenova, Anna S. Zhuk, Artem G. Lada, Irina V. Zotova, Elena I. Stepchenkova, Ivan I. Kostroma, Sergey V. Gritsaev, Youri I. Pavlov
Cancers.2021; 13(23): 5949.     CrossRef
Venetoclax, bortezomib and S63845, an MCL1 inhibitor, in multiple myeloma
Kwan Yeung Wong, Chor Sang Chim
Journal of Pharmacy and Pharmacology.2020; 72(5): 728.     CrossRef
Somatic Genomic Mosaicism in Multiple Myeloma
Christine J. Ye, Jason Chen, Guo Liu, Henry H. Heng
Frontiers in Genetics.2020;[Epub]     CrossRef
A Tangle of Genomic Aberrations Drives Multiple Myeloma and Correlates with Clinical Aggressiveness of the Disease: A Comprehensive Review from a Biological Perspective to Clinical Trial Results
Mariarosaria Sessa, Francesco Cavazzini, Maurizio Cavallari, Gian Matteo Rigolin, Antonio Cuneo
Genes.2020; 11(12): 1453.     CrossRef
Clinical impact of chromothriptic complex chromosomal rearrangements in newly diagnosed multiple myeloma
Gurvinder Kaur, Ritu Gupta, Nitin Mathur, Lata Rani, Lalit Kumar, Atul Sharma, Vishwajeet Singh, Anubha Gupta, Om Dutt Sharma
Leukemia Research.2019; 76: 58.     CrossRef
Mutational game changer: Chromothripsis and its emerging relevance to cancer
Monique Nicole Helena Luijten, Jeannie Xue Ting Lee, Karen Carmelina Crasta
Mutation Research/Reviews in Mutation Research.2018; 777: 29.     CrossRef